These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11719115)

  • 1. Further studies on an intermediate host murine model showing that a primary Echinococcus granulosus infection is protective against subsequent oncospheral challenge.
    Zhang W; You H; Zhang Z; Turson G; Hasyet A; McManus DP
    Parasitol Int; 2001 Nov; 50(4):279-83. PubMed ID: 11719115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin profiles in a murine intermediate host model of resistance for Echinococcus granulosus infection.
    Zhang W; You H; Li J; Zhang Z; Turson G; Aili H; Wang J; McManus DP
    Parasite Immunol; 2003 Mar; 25(3):161-8. PubMed ID: 12911524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinococcus granulosus: development of an intermediate host mouse model for use in vaccination studies.
    Dempster RP; Berridge MV; Harrison GB; Heath DD
    Int J Parasitol; 1991 Sep; 21(5):549-54. PubMed ID: 1743850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Echinococcus granulosus infection in lambs.
    Heath DD; Parmeter SN; Osborn PJ; Lawrence SB
    J Parasitol; 1981 Dec; 67(6):797-9. PubMed ID: 7328452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection between the cysts of Echinococcus granulosus, Taenia hydatigena and T ovis in lambs.
    Heath DD; Lawrence SB; Yong WK
    Res Vet Sci; 1979 Sep; 27(2):210-2. PubMed ID: 523807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules.
    Heath DD; Lawrence SB
    Parasite Immunol; 1996 Jul; 18(7):347-57. PubMed ID: 9229388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological characteristics of Echinococcus and their association with interventions against echinococcosis].
    Li J; Guo G; Zhang ZZ; Zhang WB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Feb; 52(2):210-214. PubMed ID: 29429281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinococcus granulosus: use of an intermediate host mouse model to evaluate sources of protective antigens and a role for antibody in the immune response.
    Dempster RP; Harrison GB; Berridge MV; Heath DD
    Int J Parasitol; 1992 Jul; 22(4):435-41. PubMed ID: 1644518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echinococcus granulosus in sheep: transfer from ewe to lamb of 'Arc 5' antibodies and oncosphere-killing activity, but not protection.
    Heath DD; Lawrence SB; Yong WK
    Int J Parasitol; 1992 Nov; 22(7):1017-21. PubMed ID: 1459779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BALB/c Mice Immunity to Hydatidosis Induced by In-vitro Reared Echinococcus granulosus Adult Worm Antigens.
    Rahimi HR; Mohammadzadeh T; Sadjjadi SM; Sarkari B; Zahabiun F
    Iran J Immunol; 2017 Jun; 14(2):123-133. PubMed ID: 28630383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal transfer of protection from Echinococcus granulosus infection in sheep.
    Dempster RP; Harrison GB
    Res Vet Sci; 1995 May; 58(3):197-202. PubMed ID: 7659840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in control of hydatidosis using vaccination--a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes.
    Heath DD; Jensen O; Lightowlers MW
    Acta Trop; 2003 Feb; 85(2):133-43. PubMed ID: 12606090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.
    Dutton S; Fleming SB; Ueda N; Heath DD; Hibma MH; Mercer AA
    Parasite Immunol; 2012 Jun; 34(6):312-7. PubMed ID: 22404504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinococcus granulosus: antigenic proteins in oncospheres and on the surface of protoscoleces identified by serum antibodies from infected dogs.
    Gasser RB; Lightowlers MW; Rickard MD
    Res Vet Sci; 1991 May; 50(3):340-5. PubMed ID: 1715595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.
    Lightowlers MW; Jensen O; Fernandez E; Iriarte JA; Woollard DJ; Gauci CG; Jenkins DJ; Heath DD
    Int J Parasitol; 1999 Apr; 29(4):531-4. PubMed ID: 10428628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of hydatid cyst fluid of Echinococcus granulosus developed in mice with secondary infection for serodiagnosis of cystic Echinococcosis in humans.
    Mamuti W; Yamasaki H; Sako Y; Nakaya K; Nakao M; Lightowlers MW; Ito A
    Clin Diagn Lab Immunol; 2002 May; 9(3):573-6. PubMed ID: 11986262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canid immunity to Echinococcus spp.: impact on transmission.
    Torgerson PR
    Parasite Immunol; 2006 Jul; 28(7):295-303. PubMed ID: 16842266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental echinococcus infection in the mouse model: pericystic cellular immunity reaction and effects on the lymphoid organs of immunocompetent and thymectomized mice.
    Fotiadis C; Sergiou C; Kyrou I; Troupis TG; Tselentis J; Doussaitou P; Gorgoulis VG; Sechas MN
    In Vivo; 1999; 13(6):541-6. PubMed ID: 10757051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the cellular immune response by a carbohydrate rich fraction from Echinococcus granulosus protoscoleces in infected or immunized Balb/c mice.
    Dematteis S; Pirotto F; Marqués J; Nieto A; Orn A; Baz A
    Parasite Immunol; 2001 Jan; 23(1):1-9. PubMed ID: 11136472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental infection of Libyan sheep with Echinococcus granulosus.
    Gusbi AM; Awan MA; Beesley WN
    Ann Trop Med Parasitol; 1991 Aug; 85(4):433-7. PubMed ID: 1796885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.